Page last updated: 2024-09-05

sorafenib and calyculin a

sorafenib has been researched along with calyculin a in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(calyculin a)
Trials
(calyculin a)
Recent Studies (post-2010) (calyculin a)
6,5207305,2519150110

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)calyculin a (IC50)
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)0.0009
Serine/threonine-protein phosphatase PP1-gamma catalytic subunitHomo sapiens (human)0.0182
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B Gallus gallus (chicken)0.0032

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biondi, RM; Brieger, A; Hinrichsen, I; Huhn, M; Passmann, S; Plotz, G; Weßbecher, IM; Zeuzem, S1

Other Studies

1 other study(ies) available for sorafenib and calyculin a

ArticleYear
Phosphorylation-dependent signaling controls degradation of DNA mismatch repair protein PMS2.
    Molecular carcinogenesis, 2017, Volume: 56, Issue:12

    Topics: Blotting, Western; Enzyme Inhibitors; HEK293 Cells; Humans; Marine Toxins; Mismatch Repair Endonuclease PMS2; Mutation; MutL Protein Homolog 1; MutL Proteins; Niacinamide; Oxazoles; Phenylurea Compounds; Phosphorylation; Proteolysis; Serine; Signal Transduction; Sorafenib; Threonine

2017